Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FELQV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,822
Award facts
- Contract value 100% obligated
- $16,822.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,822.18 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on December 12, 2025, with an ultimate completion date of December 15, 2025, represents a direct procurement under DMS Pharmaceutical Group's Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The PPV-G GEN V is a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply chain support for Department of Defense military healthcare facilities worldwide, with DMS Pharmaceutical Group serving as one of multiple regional prime vendor contractors under this framework.
DMS Pharmaceutical Group's parent IDC, designated SPE2DR and valued at $499,999,999 through December 31, 2036, authorizes the delivery of branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and medical consumables to support recurring military medical supply needs. The company has demonstrated substantial performance capability across DLA's Medical Supply Chain division, with a product portfolio encompassing oncology treatments, immunosuppressants, emergency medications, specialty surgical products, and routine pharmaceuticals. This delivery order award carries no set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement, and no subcontractor relationships are identified in the award documentation.
Quick answers
Who was awarded contract SPE2DU26FELQV?
SPE2DU26FELQV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DU26FELQV worth?
The government has obligated $16,822 on SPE2DU26FELQV.
Is contract SPE2DU26FELQV an order under another contract?
Yes. SPE2DU26FELQV is a delivery order under SPE2DU25D9421, an indefinite delivery contract.
Was contract SPE2DU26FELQV competed?
The extent of competition for SPE2DU26FELQV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award